|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $336 (December 31, 2025 - $657) | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Assets classified as held for sale | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Shareholders' (Deficit) | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued and other current liabilities | ||||||||||||||||||||
| Current portion of long-term debt, net of issuance costs | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Liabilities classified as held for sale | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Contingent consideration payable | ||||||||||||||||||||
| Long-term debt, net of issuance costs | ||||||||||||||||||||
| Deferred income tax | ||||||||||||||||||||
| Long-term portion of operating lease liabilities | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Uncertain tax position liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders' (Deficit) | ||||||||||||||||||||
| Common shares - no par value. Authorized - unlimited number. 6,972,552 issued and outstanding (December 31, 2025 - 6,859,128 - issued and outstanding) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Shareholders' (Deficit) | ||||||||||||||||||||
| Total Liabilities and Shareholders' (Deficit) | ||||||||||||||||||||
Loading...
